Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells

E. Jabbari, M. L. Ceridon, T. E. Hefferan, L. G. Pedersen, L. Lu, B. L. Currier, M. J. Yaszemski

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The cytocompatibility of poly(caprolactone fumarate) (PCLF) which is used for filling the bone defects was investigated. PCLF was developed by copolymerization of fumaryl chloride (FC) with poly(caprolactone) (PCL) that self-linked in the absence of a crosslinking agent. The PCLF scaffolds were salt leached to form a three-dimensional porous and interconnected scaffold. The results showed that the self-crosslinking linear PCLF and the crosslinked PCLF scaffolds are compatible with human fetal osteoblast cells.

Original languageEnglish (US)
Title of host publicationTransactions - 7th World Biomaterials Congress
Number of pages1
StatePublished - Dec 1 2004
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: May 17 2004May 21 2004

Publication series

NameTransactions - 7th World Biomaterials Congress

Other

OtherTransactions - 7th World Biomaterials Congress
CountryAustralia
CitySydney
Period5/17/045/21/04

ASJC Scopus subject areas

  • Engineering(all)

Fingerprint Dive into the research topics of 'Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells'. Together they form a unique fingerprint.

  • Cite this

    Jabbari, E., Ceridon, M. L., Hefferan, T. E., Pedersen, L. G., Lu, L., Currier, B. L., & Yaszemski, M. J. (2004). Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. In Transactions - 7th World Biomaterials Congress (Transactions - 7th World Biomaterials Congress).